BOSTON and MILWAUKEE — (Oct. 28, 2020) — Having already helped almost 250 new customers around the...
Moscow, October 30, 2020 –The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), União Química Farmacêutica...
Islamabad 28th October 2020: Shanghai Cooperation Organization (SCO) Startup Forum, envisioned to lay the foundation for multilateral cooperation...
Moscow, October 27, 2020 – The Russian Direct Investment Fund, (RDIF, Russia’s sovereign wealth fund), has submitted...
Islamabad 23rd Oct 2020: –Huawei today announced its business results for the first three quarters of 2020. During...
Bitcoin surged to almost $13,000 for the first time since July 2019 after PayPal Holdings Inc. announced...
Islamabad 20th October 2020:-Chinese telecommunications giant Huawei is setting up a research and development centre in Budapest,...
New virtual platforms are created for Pakistani students to exchange ideas, enhance practical skills, and contribute to...
Moscow/Hyderabad, India, October 17, 2020 – Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announce that they have received approval from the Drug Control General of India (DCGI) to conduct an adaptive phase 2/3 human clinical trial for Sputnik V...
Facebook
Twitter
Instagram
LinkedIn
RSS